D
Blueprint Medicines Corporation BPMC
$88.28 -$1.73-1.92%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 508.82M 434.41M 362.80M 282.21M 249.38M
Total Other Revenue -- -- -- -- --
Total Revenue 508.82M 434.41M 362.80M 282.21M 249.38M
Cost of Revenue 20.16M 12.93M 15.55M 11.52M 12.80M
Gross Profit 488.66M 421.48M 347.24M 270.69M 236.58M
SG&A Expenses 359.27M 342.14M 322.95M 305.54M 292.94M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 720.87M 710.37M 718.75M 723.10M 735.66M
Operating Income -212.05M -275.95M -355.96M -440.89M -486.28M
Income Before Tax -65.86M -127.43M -204.95M -287.66M -506.01M
Income Tax Expenses 1.23M 616.00K 540.00K 628.00K 968.00K
Earnings from Continuing Operations -67.09 -128.05 -205.49 -288.29 -506.98
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -67.09M -128.05M -205.49M -288.29M -506.98M
EBIT -212.05M -275.95M -355.96M -440.89M -486.28M
EBITDA -195.75M -262.13M -343.13M -428.10M -474.61M
EPS Basic -1.02 -2.06 -3.37 -4.77 -8.37
Normalized Basic EPS -2.62 -3.22 -4.04 -4.92 -5.40
EPS Diluted -1.07 -2.11 -3.42 -4.82 -8.37
Normalized Diluted EPS -2.59 -3.19 -4.01 -4.89 -5.40
Average Basic Shares Outstanding 251.42M 248.71M 246.01M 243.67M 242.22M
Average Diluted Shares Outstanding 253.64M 250.93M 248.23M 245.90M 242.22M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings